IV Fluids and Post-ERCP Pancreatitis
Association Between Peri-procedural Intravenous Hydration and Post- Endoscopic Retrograde Cholangiopancreatography Pancreatitis
University of Calgary
13,000 participants
Jan 10, 2022
OBSERVATIONAL
Conditions
Summary
Aggressive intravenous hydration has been shown in randomized trials to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), though studied regimens are often impractical. To date, no studies have prospectively assessed short-term (60-90 minute) aggressive hydration regimens that are feasible for outpatients undergoing ERCP and subsequent discharge. Furthermore, little is known with regard to fluid type, volume, and timing with respect to ERCP. In this study, we will aim to assess whether the amount of peri-procedural intravenous fluid administered around the time of ERCP is associated with the risk of PEP (the primary outcome).
Eligibility
Inclusion Criteria3
- Subject referred for ERCP, regardless of indication;
- Subject age 18 years or older;
- Subject able to give informed consent to involvement be included.
Exclusion Criteria3
- Subject has a standard contraindication to ERCP;
- Subject or surrogate unable or unwilling to provide informed consent;
- Subject age < 18 years.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Amount of intravenous fluids delivered
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05211206